Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 87B is a eukaryotic membrane protein that structurally belongs to the GOLD domain seven-transmembrane helix (GOST) family, closely related to TMEM87A, GPR107, and GPR108[2][5]. It is specifically involved in retrograde protein trafficking within the cell, especially to and from the Golgi apparatus, and plays roles in developmental signaling and cardiac tissue development[3][4][1]. Mutations or disruptions of TMEM87B are associated with congenital heart defects and copy-number variation syndromes such as 2q13 microdeletion syndrome[4]. TMEM87B exhibits high expression in the brain and heart[4], with possible roles in certain developmental disorders and malignancies, but its function as a mechanosensitive ion channel or as a classical G protein-coupled receptor is structurally and biologically disputed[2][5]. There is no evidence that TMEM87B is a pharmacological target, and no drugs or mechanisms of action have been identified for this molecule[3][4][5].
Not applicable; there are no drugs known to target TMEM87B
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 87B (TMEM87B).